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ABSTRACT 14 
Video-reflexive ethnography (VRE) is a qualitative methodology that explores the complex nature of 15 
healthcare ‘as it really is’. Its collaborative and reflexive process invites stakeholders (e.g. 16 
pharmacists and pharmacy support staff) to participate in analysing their everyday work practices as 17 
captured on video footage. Through close collaboration with practitioners and attention to their 18 
work contexts, VRE may be a useful methodology to engage a time-poor pharmacy workforce in 19 
research about themselves, encouraging more practitioner involvement in practice-based research. 20 
Aside from research, VRE has also been used effectively as an intervention to facilitate learning and 21 
change in healthcare settings, and could be effective in provoking change in otherwise resistant 22 
pharmacy environments.  23 
Much like traditional ethnographic approaches, VRE researchers have relied on being present ‘in the 24 
field’ to observe, record and make sense of practices with participants. The COVID-19 pandemic 25 
however, has introduced restrictions around travel and physical distancing, which has required 26 
researchers to contemplate the conduct of VRE ‘at a distance’, and to imagine new ways in which 27 
the methodological ‘closeness’ to stakeholders and their workplace contexts can be maintained 28 
when researchers cannot be on site. 29 
In this commentary, we outline the rationale for participatory methods, in the form of VRE, in 30 
pharmacy research. We describe the underlying principles of this innovative methodology, and offer 31 
examples of how VRE can be used in pharmacy research. Finally, we offer a reflexive account of how 32 
we have adapted the method for use in community pharmacy research, to adapt to physical 33 
distancing, without sacrificing its methodological principles. This paper offers not only a new 34 
methodology to examine the complexity of pharmacy work, but demonstrates also the 35 
responsiveness of VRE itself to complexity, and the potential breadth of future research applications 36 
in pharmacy both during and beyond the current pandemic. 37 
Keywords: video-reflexive ethnography, community pharmacy, stakeholders, methodology 38 
Introduction 39 
The work of community pharmacists across the world is significantly impacted by pharmacy practice 40 
research. As in USA,1 Australia,2 and many other countries, pharmacy practice research into 41 
cognitive pharmacy services have demonstrated their economic benefits,3-8 resulting in their 42 
incorporation into public health programs. For example, in Australia, the work of academia, 43 
pharmacy associations and government bodies to implement these initiatives have resulted in 44 
significant changes in community pharmacy practice.9-12 However, few studies have investigated the 45 
direct effects of these changes on the pharmacy workforce. In the UK, research into the effects of a 46 
new federal contract funding administrative and additional services showed an increase in mental 47 
and quantitative workload, and increased strain and turnover in community pharmacists.13-16 It is 48 
likely the pharmacist workforce internationally are experiencing similar challenges with the fast rate 49 
of change.17.  50 
The active engagement of front-line pharmacist voices in certain aspects of the research process 51 
(e.g. the formulation of research questions, data analysis, interpretation and translation of findings 52 
into practice) is necessary in order for pharmacy practice research to remain directly translatable to 53 
the profession. Allowing frontline clinicians to analyse, discuss and potentially translate findings back 54 
to their everyday work settings could be transformational in impact. While clinician participation in 55 
content validation appears to be the norm in qualitative pharmacy research, the lack of frontline 56 
clinician involvement in other research processes (e.g. co-analysis and formulating research 57 
questions) could limit the value and impact of research findings into the pharmacy setting. 58 
It should be noted at this point that active engagement of pharmacists in research has not been an 59 
easy task, historically. Various research around the world has shown that pharmacists do not 60 
frequently engage with research teams, citing workload and time constraints despite recognising its 61 
value.11, 18-23 Other factors such as lack of training or post-graduate studies are known to affect 62 
pharmacists carrying out research.20-23 We discuss some other possible reasons below.   63 
Video-reflexive ethnography (VRE) as a participatory action research method 64 
It has been acknowledged that new approaches to community pharmacy research are necessary: 65 
complex social phenomena, behaviours and beliefs are not well suited to quantitative approaches.24, 66 
25 The value of qualitative study methods in eliciting such information could be indispensable26 in 67 
better documenting the contrary behaviour displayed by pharmacists towards providing new health 68 
services and engaging in research.  69 
As an example, a poor understanding of pharmacist work and outdated workload measurements 70 
(which were often gathered using quantitative data collection27) may be a cause of current 71 
workforce issues.16, 28-33 This may be because community pharmacist work is more complex than 72 
previously recognised.16, 30, 34 Many processes are enacted by different pharmacy team members and 73 
may occur in swift or parallel succession, under the watchful eye of the pharmacist and general 74 
public whom they directly interact with.35-41 Such processes must be multi-tasked whilst also 75 
maintaining a watchful eye on the running of the pharmacy.35, 37, 42 Additionally, the role of the 76 
community pharmacist is commonly misperceived by other healthcare professionals and the public 77 
alike, who may see them as little more than glorified medication shopkeepers.43-47 Lastly, new 78 
intervention protocols tend to be clinically focused and do not always consider how services may be 79 
perceived and integrated into existing workflows for front-line community pharmacists, who must 80 
supervise the pharmacy on top of their clinical duties.35, 37, 42 This has perhaps resulted in a 81 
pharmacist workforce that may be wary of outsider influences, including external researchers.11, 18, 19 82 
It has been said that pharmacists are more likely to engage in research where they have a personal 83 
interest in the topic of research, and the belief that pharmacy practice research is beneficial, 84 
especially to their patients.11, 18, 19 Participatory forms of research, therefore, may be attractive to 85 
this population. In particular, participatory approaches that engage with frontline practitioner 86 
knowledge and the complexity of their work. These could assist in explaining, for instance, the 87 
behaviour of pharmacists who profess their support of new cognitive pharmacy services, but in 88 
practice, do not preferentially provide these services.28, 29  Applying the participatory principle of 89 
‘nothing about us without us’48 into pharmacy practice, through research, could be transformational 90 
for the community pharmacy setting.  91 
That said, participatory action research is not new to pharmacy practice. Various participatory action 92 
research methods have been used in studies, including the co-design and creation of pharmacy 93 
services,49, 50 understanding how action research studies can change pharmacy work practices,51 and 94 
various hospital pharmacy improvements projects.52, 53 This has included methods such as 95 
participatory and social mapping, pictures/photovoice, Spider-grams, ranking and scoring, seasonal 96 
calendars, life histories, narratives and storytelling, problem trees and human sculptures.54 In 97 
general, different methods are used for exploration of subjective or social experiences, such as 98 
power hierarchies, social relationships, personal satisfaction with services, and understanding 99 
physical or social conditions.54   100 
However, it has been reported that pharmacy practice research requires more experienced 101 
researchers in participatory action research and qualitative studies in general,51, 54 and various 102 
factors can make its application complex. Participatory research requires a complex process that 103 
would be best guided by those with pre-existing experience. For example, the relationship between 104 
researcher and participants/collaborators is key, since trust is an important feature for the success 105 
of the study. Similarly, research teams must understand the research context well enough to both 106 
initiate and sustain the intervention in a way that is ethical and collaborative, requiring some 107 
flexibility of the team. The research process itself is sometimes multimodal and/or cyclical in nature, 108 
and may require constant negotiation with participants, plus ongoing reflection and reflexivity from 109 
the research team. However, the embedded nature of such research produces rich outcomes and a 110 
depth of meaning which can be transferrable to comparable settings. Its iterative nature means 111 
practice improvements and changes can result during the research. It is also particularly suited to 112 
constantly changing environments, such as the community pharmacy setting, due to the flexibility of 113 
the research process.51, 54  114 
VRE is one such participatory methodology that has become increasingly popular in the last decade, 115 
for studying (and intervening in) the complexity of frontline healthcare work. Drawing on 116 
ethnographic and participatory research traditions, researchers collaborate with study participants 117 
to record and select video footage of their everyday work practices. These videos are then replayed 118 
to the participants in reflexive discussions facilitated by researchers. Viewing the footage enables 119 
participants to view and analyse their actions as a third party, allowing them to distance themselves 120 
from their behaviour, thus making ‘what is familiar strange’.55 Aside from the video-recording of 121 
practices and the facilitation of reflexive discussions, VRE methods can also include observation, 122 
interviews, documentary analysis, and other ethnographic methods which allow the researcher to 123 
explore the context of interest. The primary aim of these methods is to make the complexity of their 124 
work practices more visible, and tangible, to practitioners, and hence encourage and inspire analysis 125 
and change.56  126 
VRE has been used not only for research, but also as an intervention. Examples of previous 127 
interventions in healthcare settings worldwide include improving: infection control in hospitals,57, 58 128 
ICU clinical communication processes,59 inpatient dementia care,60 and shared decision making in 129 
primary care,61 involving both clinicians and patients. In some cases, the methodology has been 130 
adopted by hospitals as their commitment to ongoing quality improvement, after successful 131 
completion of VRE projects.62 VRE represents an opportunity to review and improve clinical 132 
performance without the threat of deregistration, insurance claims or litigation, which can be rare 133 
for health professionals like pharmacists.63-65 VRE has also been used in pharmacist populations as 134 
part of two multidisciplinary studies. Kaiser Permanente Southern California South Bay Medical 135 
Center in the USA used VRE to improve their quality of transitional care by shadowing various 136 
assessments by health care professionals, including pharmacists66; and a current UK study protocol 137 
describes using VRE to investigate polypharmacy in 3 GP clinics and 4 community pharmacies, 138 
including patient consultations from March 2016 to February 2021.67  Lastly, similar use of video in 139 
pharmacy practice education to enable students to reflect on and improve their counselling 140 
practices is well established.68  141 
However, as a participatory action methodology, VRE does not just study recorded behaviours and 142 
actions for quality improvement. It also involves guided facilitation and questioning to elicit 143 
participant responses to: how the video has been captured by the researchers and/or participants; 144 
the social/physical/interactional contexts that are visible or not visible in the video; reflection on 145 
reasoning for cinematographic choices and biographical context; and the contextualisation of 146 
everyday care practices. This awareness of what is not visible in the footage allows the facilitator to 147 
invite multiple meanings from various perspectives of those involved in the study, and provides 148 
greater insight into the phenomena being studied. The basic principles of VRE methodology are 149 
described below in greater detail.   150 
The epistemology of VRE: an overview of VRE study design considerations 151 
VRE researchers developed its theoretical foundations from several origins, including practice 152 
theory, educational philosophy, science and technology studies, and participatory action research.69  153 
To guide researchers new to the methodology, its theoretical framework has recently been 154 
articulated as a set of four guiding principles, exnovation, reflexivity, collaboration and care56 which 155 
are described as follows. 156 
1. Exnovation 157 
VRE acknowledges that the creative enactment of everyday clinical practice often goes unnoticed, 158 
perhaps due to repetition (habit) or the distraction and pace of busy workplaces. Those using VRE 159 
seek to make visible this ‘local ecology of care’ where the actions of a clinician can be seen as 160 
embedded in the workplace contexts where they unfold. This process of exnovation is designed to 161 
make tangible the complexity of healthcare work, and make visible the creativity, competence and 162 
expertise of healthcare workers.  163 
In practice, this means that video-reflexive ethnographers are interested in how everyday practices 164 
unfold, creating (and making sense of) video footage of those practices in collaboration with front-165 
line clinicians and patients.  166 
For example, it has been established that community pharmacists commonly multi-task in order to 167 
complete their work.28, 29, 35, 37, 42 A VRE study might involve video recordings of the pharmacists 168 
working, and a reflexive discussion around how different tasks were prioritised and selected in the 169 
viewed footage. Responding to the footage might elicit comments about contextual pressures that 170 
change pharmacist task prioritisation (e.g. waiting customers), practitioner understanding of how 171 
the pharmacist role should be enacted (e.g. behaviours seen as acceptable/distasteful), or how 172 
pharmacist task priorities were shaped by professional socialisation (e.g. university/internship 173 
training and work experiences). This, in turn, could inform the researcher about how interplay of 174 
visible (through the video) and invisible (e.g. mental processes and preferences) factors might 175 
impact pharmacist negotiation of their tasks. This use of VRE could explore the subjective mental or 176 
cognitive workloads of pharmacists in depth, closely associated to their work contexts. 177 
2. Reflexivity 178 
Due to its incorporation into student curricula and professional development plans,70-72 pharmacists 179 
may be familiar with reflection as a personal activity for contemplating one’s own actions, and an 180 
opportunity for learning. Reflexivity, however, as described in VRE, also takes into account the 181 
context in which actions and behaviours happen, such that participants’ actions and behaviours are 182 
framed within the impact of others’ actions and behaviours, and vice versa.69 In this way, reflexivity 183 
promotes critical awareness of individuals’ conduct within layers of context, including their own 184 
backgrounds, socio-political context of their workplaces, physical environment, profession, and so 185 
on.73 For researchers, decisions of what should be video recorded and played back, and how 186 
reflexive sessions are held and facilitated are also determined through ongoing reflexivity. Reflexivity 187 
is expected from all parties involved (professionals, researchers and patients) and is necessary 188 
throughout all project stages.74 189 
In practice, reflexive sessions involve researcher-facilitated viewings of recorded footage with 190 
participants, who may be those featured in the footage, colleagues, or others who are familiar with 191 
and/or have a stake in the practices shown. In viewing their footage, guided by researchers’ 192 
questions, participants are invited to see their behaviour, within its context, from different 193 
viewpoints, and to respond to the complexity of the local healthcare setting. 194 
This enables a critical review of healthcare practices by stakeholders, encouraging a re-imagination 195 
of care: why do we work this way, is this appropriate, what else could be done, what could be 196 
improved? For example, in viewing footage, community pharmacists may become more aware of 197 
their multitasking as they describe their need for task prioritisation, and may see opportunities for 198 
prioritising their work differently. Researchers may find previous assumptions about pharmacist 199 
work and interaction with the work environment challenged at this stage. An example of researcher 200 
reflexivity will be described in the section below.  201 
3. Collaboration 202 
In line with the principle of exnovation, which seeks to foreground and harness frontline actors’ 203 
expertise and understanding of their own practices, VRE invites stakeholders (e.g. pharmacists, 204 
dispensary technicians, patients) to participate as co-researchers, working alongside researchers to 205 
create and analyse footage, and to re-imagine and redesign work processes.  206 
This collaboration is key, as stakeholders are active participants in the context of the health care 207 
setting, with an experiential understanding of its inner workings. Since researchers work with 208 
stakeholders to decide what footage is significant and should be recorded, videos discussed in a 209 
reflexive session are inherently important to both the researchers and stakeholders. The reflexive 210 
discussions arising from viewing the footage thus reflect researchers and stakeholders engaging in 211 
‘sense-making’ of the practices under scrutiny. Findings of a VRE study are therefore produced 212 
through both ‘insider’ (i.e. stakeholders) and ‘outsider’ (i.e. researcher) perspectives,56, 73 which may 213 
therefore be more readily translated into evidence-based, practical outcomes by combining 214 
theoretically-based researcher reflexivity, and experientially-based practitioner reflexivity. This 215 
strength of participatory research can be applied to many areas of pharmacy practice.  216 
For example, within a community pharmacy, VRE researchers could consult with local pharmacists 217 
about what activities to record around cognitive pharmacy service provision. This could include 218 
pharmacist multitasking, patient recruitment, dispensary movements, use of counselling rooms, 219 
service interruptions and pharmacist responses to changing pharmacy environments. During 220 
reflexive sessions, the researchers would then take on the role of a curious facilitator to make sense 221 
of footage with the pharmacists. This allows them to create meaning from the recordings together, 222 
rather than separately, at a distance from one another and the context at hand. This collaborative 223 
analysis of multitasking and task prioritisation in relation to cognitive pharmacy services could lead 224 
to a better understanding of pharmacists’ behaviours when set in their context. These findings 225 
would lead to increased impact, since the context has already been taken into consideration and 226 
outcomes could be more practically implemented.  227 
4. Care 228 
In this final principle, VRE researchers acknowledge that feelings of vulnerability are part of the VRE 229 
process, as the process of allowing one’s behaviour to be recorded and examined by oneself and 230 
important others, including colleagues and managers, can be stressful and confronting. Video 231 
footage can also be easily misused, for instance, for performance monitoring by management who 232 
may impose sanctions, exposing vulnerability of participants with low control or power (e.g. patients 233 
and healthcare workers lower in the medical hierarchy). This is contrary to the purposes of VRE, 234 
which is designed to improve learning and interventions, rather than blame and personify errors. 235 
This last principle of care, therefore, emphasises the well-being of participants (and researchers) as a 236 
core tenet of the success of this methodology. The collaborative and reflexive processes of VRE 237 
enable researchers to monitor and negotiate situations and relationships with participants, to 238 
ensure that they are not adversely affected by participating in research. Furthermore, ensuring care 239 
for participants involves creating and maintaining their psychological safety, to enable open and 240 
frank discussion of recorded behaviours that are watched, edited and analysed by others. This is 241 
done through respectful engagement, facilitating open discussion, and an ongoing commitment to 242 
consent at every stage. For instance, this means that participants are regularly and continuously 243 
asked for their consent: to participate in the study, to be recorded, to have their footage kept and 244 
used, to have their footage shown to others, and so on.  245 
This is important in healthcare settings such as the community pharmacy sector, where 246 
organisational hierarchy and power structures can complicate pharmacists’ autonomy and their 247 
subsequent practice. For example, in this era of patient-centred care, many pharmacists require 248 
professional autonomy to provide clinical care through cognitive pharmacy services.75, 76 However, 249 
corporatisation of pharmacy business structures often result in the removal of some economic 250 
agency from the pharmacists accountable for the business, since their actions relate directly to 251 
pharmacy profitability.77 In one study, this was accompanied by a sense of loss of control and 252 
decision-making ability.76 In these situations, pharmacists may not have the economic autonomy to 253 
redirect resources towards increasing service quality due to the hierarchy of power in pharmacy 254 
organisations, particularly corporate and franchise business structures.77-79 Quite likely, this potential 255 
affront to professional autonomy may be related to the negative reactions of pharmacists towards 256 
service targets that focus on quantity.13, 16, 80 Thus, increased levels of strain reported in pharmacist 257 
populations may be directly related to power imbalances and conflict potentially unacknowledged 258 
by pharmacy leadership.80-82  259 
Much like the concept of a ‘just culture’ in patient safety,83 VRE creates a psychologically safe 260 
environment for clinicians to learn from observed footage and improve their care, and could be an 261 
important research approach to examine and potentially address participant work-related strain.  262 
The researcher’s role in VRE, then, is to protect participant wellbeing and ensure the research 263 
process is customised to allow full and honest participation. A synergistic effect should be occurring 264 
where ideally, clinicians are the experts leading the researcher through their everyday care 265 
practices, which is in turn being facilitated and documented by the researcher-led processes for 266 
further analysis and learning.   267 
Applying VRE to pharmacy practice – managing distances 268 
Above, we described how VRE enables participants and researchers to examine and intervene in the 269 
complexity of everyday work practices. In doing so, it may bridge the evidence-practice gap that 270 
characterises much of health services research and policy-making.84, 85 271 
In VRE, this is achieved by an interplay of closeness and distance: close engagement during research 272 
with practitioners and their actions embedded in their contexts; but also introducing ‘distance’, 273 
through the researcher’s (outsider) presence and perspective; additionally, participants gain a kind 274 
of third-party perspective by watching their own footage. The effect of this ‘distance’ serves to direct 275 
practitioners’ attention and interest to overlooked aspects of their practices, in order to reimagine 276 
them. Thus evidence is both created and applied, by practitioners and researchers, close to the 277 
relevant contexts of practice. 278 
As a result of the COVID-19 pandemic, new challenges pertaining to distance have been introduced 279 
to VRE research, especially the physical distancing and travel restrictions for the prevention of 280 
community transmission. To adjust to this new problem of distance, in the next section an 281 
adaptation of the methods of VRE in one pilot study is discussed, through reflexive engagement with 282 
the four guiding principles. 283 
An adaptation for geographic restrictions and pandemic conditions 284 
As described in the examples above, cognitive service provision work in community pharmacies 285 
requires further investigation, since pharmacists appear not to provide these services despite 286 
demonstrating enthusiasm for them.13, 15, 16, 86 Although community pharmacy practice 287 
internationally has transitioned towards a focus on cognitive pharmacy services,2, 17, 87-90 pharmacy 288 
productivity indicators remain predominantly tied to dispensing-related measures.41, 91-93 This may 289 
have potentiated pharmacy worker strain and overload,81, 94 by not taking into account the new ways 290 
of working involved in service provision.28, 29 A mismatch between today’s workload and its 291 
measurement are not easily investigated by traditional research methods (observations, surveys and 292 
focus groups), which often take place ‘at a distance’ from the internal complexities of pharmacists’ 293 
work practices.35, 37, 41, 42 It could be that pharmacist workload and productivity measures require 294 
updating in this new era of patient-centred care. In Australia, this could be because current 295 
workload and productivity measures tied to staffing and resource availability may be implicated in 296 
increased pharmacist workforce strain, causing dissatisfaction and turnover.28, 29, 81 This, in turn, may 297 
be complicated by multiple roles enacted by front-line pharmacists,95, 96 some of which have arisen 298 
from research academics, professional associations and government policies.17  299 
To explore how today’s practice environment may affect the behaviour and actions of community 300 
pharmacists towards their work and cognitive pharmacy service provision, VRE was chosen for its 301 
collaborative, contextualised research approach.  302 
Due to the remote nature of some Australian community pharmacies and the government-303 
mandated physical distancing during the COVID-19 pandemic, we designed a pilot study that took a 304 
participant-led approach to VRE, emphasising in particular the ‘collaboration’ guiding principle, and 305 
seeking to harness the expertise of community pharmacists as reflexive analysts of their own work 306 
practices.  307 
With respect to the principle of care, we chose to request pharmacists to video record themselves 308 
and have them share and discuss this footage online with us, rather than potentially expose 309 
researchers, participants and communities to COVID-19. Instead of researchers physically being 310 
present to capture video footage onsite, participating pharmacists were asked to video-record short 311 
(10 minute) segments of their everyday work, and to submit this footage for use as research data, 312 
using their own devices. To protect the privacy of third parties such as patients and customers, any 313 
submitted video footage including their faces are de-identified using video-editing software. 314 
Participants are asked to not record any audio, and participants were also reminded to delete their 315 
own copies of footage involving third parties. As a further consideration, study participants are to 316 
inform and post study notices for pharmacy staff and patients, who are given the choice to view and 317 
delete any recordings they may be captured in.  318 
In keeping with the principle of exnovation, researchers explained aims of the study and gave advice 319 
on selecting routine practices to participants to guide them in recording videos for submission. In the 320 
same way VRE researchers would normally have to justify what they record, participants were asked 321 
to reflexively consider their reasons for recording videos. At the point of footage submission, 322 
participants briefly described reasons for footage selection in writing.  Video footage was then 323 
selected for use in the reflexive sessions based on participants’ written rationales, research team 324 
review and study objectives. 325 
In order to facilitate collaboration between researchers and participants, it was decided the reflexive 326 
sessions would be split into two stages. First, individual online sessions with a researcher would be 327 
held to elicit participant reflexivity. The second stage of reflexive sessions were designed for 328 
researchers to present the findings of the study to all participants who would be invited to attend, 329 
and garner their views on study outcomes.  All reflexive sessions are audio and video recorded, and 330 
transcribed for content analysis. This two-stage design was chosen to allow sufficient care and 331 
reflexivity for researchers and participants, whilst maintaining an opportunity for multiple 332 
perspectives on study findings to be shared in a group setting.  333 
This modification of the VRE process to include participant-led video recording is novel and enhances 334 
the participatory principles of VRE. By limiting researcher input into video recording, participants can 335 
take the lead in foregrounding their work practices, using their lived-in understanding of work 336 
contexts. Although support and guidelines for video recording were supplied, participants were told 337 
to consider what they felt important about pharmacist work when choosing what to record and 338 
submit. The research team was then ‘introduced’ by participants to these contextualised insights in 339 
reflexive sessions for a truly collaborative participant-led approach. This requires participants to 340 
engage in reflexivity regarding their selection of footage throughout the process.  341 
The necessity of researcher reflexivity 342 
Further, the research team consists of a currently practising community pharmacist completing 343 
doctoral studies (*), a pharmacist professor (**) and a health services researcher and social scientist 344 
(***). During the planning of this pilot study, numerous discussions surrounding researcher roles 345 
during the reflexive sessions were held. It was decided that (*), with an insider view into this work 346 
context, would conduct these sessions to assist in drawing out implied and assumed practitioner 347 
knowledge. Specific care was also taken to consider what care and collaboration signified in this 348 
study. For example, pharmacists are accustomed to tailoring their social interactions to their role 349 
partners.75 It was thus important to continually reinforce the research team’s desire for participants 350 
to demonstrate their expertise of their practice, rather than catering to perceived researcher 351 
desires. For instance, during reflexive sessions, an active listening approach was used to reflect 352 
participant statements back to them, and confirm views to avoid assumptions.  353 
This participant-led approach contrasts with the previously established role of the researcher in 354 
carrying out VRE. Typically, video-reflexive ethnographers negotiate video footage recording with 355 
front-line clinicians and patients, making methodological decisions surrounding camera point-of-356 
views and similar considerations. However, rather than being a disadvantage, this adaptation 357 
remains true to the VRE principles of exnovation, reflexivity, collaboration, and care.  358 
Ethnography is, in itself, a process in which the researcher can contextualise the research data into 359 
the lives of the participant in question. This requires time and understanding through the use of 360 
observations, note-taking and reflexive commenting from both the researcher and the participant in 361 
VRE. We consider that this particular use of VRE was offering a form of cultural brokerage97 to 362 
pharmacists who complained their work was not recognised in an earlier unpublished study by (*), 363 
some of whom also opted-in to this study. It may have been empowering for pharmacists who may 364 
feel their professionalism is unseen, and their concerns for their occupational health unheard. It 365 
could be that community pharmacists, in wanting to appear as professional healthcare clinicians, 366 
have been rather too successful in performing their work in an easy, streamlined manner. When 367 
designing this study, the intention had been to describe the complex world of the community 368 
pharmacist and the rich interactional work they participate in, including the unseen restrictions 369 
represented by legal, professional and ethical frameworks. Being conscious of the positivist 370 
traditions in the profession, this methodology was chosen to peel back the layers of factors that 371 
motivate pharmacists to behave as they do. Treating the video footage as visual records of their 372 
work practices, (*) asked questions about their reasons for capturing their footage, and their 373 
rationale for their particular way of working, thus requiring them to view their own setting, practices 374 
and professional identity with reflexivity. Although viewing of video footage alone was not 375 
ethnographic, the reflexive discussions it sparked allowed pharmacists to assign unseen meaning to 376 
particular processes. For example, one participant rejected the idea that a community pharmacist 377 
was merely a medication expert or accessible health professional, instead strongly advocating that 378 
all pharmacist tasks were representative of different parts of their professional identity, which 379 
needed to be described by multiple terms. The description of their working process revolved around 380 
their workflow, patient needs and time afforded to them between patient interactions, wherein they 381 
slotted in administrative tasks such as updating restricted drug records and follow-up patient calls. 382 
Challenges of VRE adaptation within the COVID-19 pandemic in the Australian setting 383 
As a pharmacist-researcher (*), the differing paradigms of pharmacy practice research and 384 
community practice have become clearer. Although pharmacist clinicians typically write from a 385 
positivist paradigm (as other health professionals do, and struggle to depart from),98 it could be the 386 
ability of community pharmacists to contextualise advice and appreciate multiple client realities75 387 
demonstrates appropriateness in utilising this participatory approach. A constructivist approach 388 
compatible with symbolism and sense-making is required for both negotiating the complexities of 389 
everyday healthcare practices, and engaging in research co-analysis with participants. Rather than 390 
imposing the researcher’s own perspectives upon observations and participant dialogue, VRE 391 
enables the researcher to work with stakeholders to both create and interpret findings. As such, VRE 392 
co-analysis and flexibility towards multiple meanings necessitates a critical research framing. This 393 
may have some challenges for clinicians and researchers who are unfamiliar with the social 394 
sciences.98  395 
However, the acceptability of this study was not high during this pandemic: the length of 396 
involvement and enthusiasm required from participants led to recruitment challenges, particularly 397 
as workloads were already increased by COVID-19 regulations (as explained by our participants). 398 
Although there was some initial interest when we began recruitment, many did not respond beyond 399 
their expressions of interest. One pharmacist cited a lack of approval from their proprietor who had 400 
read the disclaimer for disclosure of illegal behaviour, despite the fact their employee would be self-401 
recording and selecting footage involved. Another described with great distress how they were 402 
overworked and could not participate, due to concurrent participation in a different study. Overall, it 403 
appeared that participants with previous involvement with research or interaction with the research 404 
team were more likely to participate. Additionally, those who believed pharmacists could be better 405 
acknowledged for their work were more motivated to produce better quality data. Whilst 406 
engagement with pharmacists is originally described to be difficult, it may be even harder to recruit 407 
for a VRE study from a distance, where the relationship between researcher and participants is key. 408 
It was with some irony we noted we were asking pharmacists to do additional ‘work’ for the study in 409 
order to understand their initial workload problems.  410 
Implications 411 
Although the pilot study described in this paper did not have the scope to include pharmacy staff, 412 
patients and collaborative health professionals, findings from this study could influence a larger 413 
scale study design that would be more approachable for pharmacists, and thus amenable to the 414 
inclusion of other parties. 415 
Furthermore, participatory research approaches like VRE could encourage research engagement in 416 
community pharmacists, since they have an opportunity to direct research towards issues of interest 417 
towards themselves, and see their potential benefit first-hand. One suitable topic, as described 418 
above, might be about pharmacist interactional and mental work processes.31, 35, 37, 42 Workforce 419 
research would also benefit from the use of VRE, since it would situate workforce issues within 420 
workplace contexts, including unseen stresses/pressure and role conflicts. As learning interventions 421 
for the implementation of services, and cognitive pharmacy service quality improvement, the use of 422 
VRE could be investigated further, since associated pharmacist behaviour and actions are not well 423 
documented. Other areas that are traditionally difficult to investigate could potentially be addressed 424 
through VRE, such as how Aboriginal and Torres Strait Islander communities interact with pharmacy 425 
services; how persons of migrant, refugee and disadvantaged backgrounds experience pharmacies; 426 
and the use of translator services. Drawing on the success of VRE in investigating these issues with 427 
clinicians in hospitals, other areas of application could include the use of protocols with pharmacy 428 
support staff (i.e. pharmacy assistants and technicians), information handovers, and professional 429 
identity. In general, VRE could be an useful and flexible method, due to its caring, participatory and 430 
collaborative nature, and sensitivity towards participants.  431 
Conclusions 432 
VRE can be effective in pharmacy settings as both an intervention and an exploratory research 433 
approach. A key characteristic of VRE is the flexibility afforded to researchers in conducting research, 434 
in return for constant reflexivity about methodological principles, as demonstrated above. For 435 
researchers, a thorough understanding of the theoretical underpinnings of VRE are therefore 436 
important to ensure appropriate use.24, 56  437 
VRE presents an exciting opportunity for pharmacy practice researchers to solve questions such as 438 
the contrary behaviour of front-line clinicians who profess approval of cognitive pharmacy services 439 
but do not always provide them. Furthermore, it gives voice to front-line community pharmacists, 440 
and potentially in the future, pharmacy staff and patients. This may encourage research engagement 441 
and future scholarship. This could be an effective way to explore issues in the pharmacist workforce 442 
undergoing role transition.99 As an established methodology, VRE can engage with complexity and 443 
contradictions in human behaviour, which may be highly transformative in future pharmacy practice 444 
research.  445 
References 446 
1. Baldwin JN, Bootman JL, Carter RA, et al. Pharmacy Practice, Education, and Research in the 447 
Era of Big Data: 2014-15 Argus Commission Report. Am J Pharm Educ. 2015;79:S26-S26. 448 
2. Moles RJ, Stehlik P. Pharmacy Practice in Australia. The Canadian journal of hospital 449 
pharmacy. 2015;68:418-426. 450 
3. Malet-Larrea A, García-Cárdenas V, Sáez-Benito L, Benrimoj SI, Calvo B, Goyenechea E. Cost-451 
effectiveness of professional pharmacy services in community pharmacy: a systematic 452 
review. Expert Rev Pharmacoecon Outcomes Res. 2016;16:747-758. 453 
4. Gammie T, Vogler S, Babar Z-U-D. Economic Evaluation of Hospital and Community 454 
Pharmacy Services. Ann Pharmacother. 2016;51:54-65. 455 
5. Publications Committee of the American College of Clinical P, Schumock GT, Meek PD, Ploetz 456 
PA, Vermeulen LC. Economic Evaluations of Clinical Pharmacy Services—1988–1995. 457 
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 1996;16:1188-458 
1208. 459 
6. Touchette DR, Doloresco F, Suda KJ, et al. Economic evaluations of clinical pharmacy 460 
services: 2006-2010. Pharmacotherapy. 2014;34:771-793. 461 
7. Benrimoj SI, Langford JH, Berry G, et al. Economic Impact of Increased Clinical Intervention 462 
Rates in Community Pharmacy. Pharmacoeconomics. 2000;18:459-468. 463 
8. Schumock GT, Butler MG, Meek PD, et al. Evidence of the Economic Benefit of Clinical 464 
Pharmacy Services: 1996–2000. Pharmacotherapy: The Journal of Human Pharmacology and 465 
Drug Therapy. 2003;23:113-132. 466 
9. Pharmacists in 2023: For patients, for our profession, for Australia's health system. 467 
Canberra: The Pharmaceutical Society of Australia Ltd. ; 2019. 468 
10. Cutler RL. The UTS Community Pharmacy Barometer. Sydney, Australia: University of 469 
Technology Sydney; 2018. 470 
11. B Saini, M Brillant, J Filipovska, et al. Recruitment and retention of community pharmacists 471 
in pharmacy practice research. In: Saini B, ed. Sydney, Australia: Faculty of Pharmacy, 472 
University of Sydney; 2005. 473 
12. Moullin JC, Sabater-Hernández D, Fernandez-Llimos F, Benrimoj SI. Defining professional 474 
pharmacy services in community pharmacy. Research in Social and Administrative Pharmacy. 475 
2013;9:989-995. 476 
13. Bond CM, Blenkinsopp A, Inch J, Celino G, Gray NJ. The effect of the new community 477 
pharmacy contract on the community pharmacy workforce. Medicines & People: Turning 478 
knowledge into Know-How: The Pharmacy Practice Research Trust; 2008. 479 
14. Gidman WK, Hassell K, Day J, Payne K. Does community pharmacy offer women family-480 
friendly working conditions and equal opportunities? the accounts of female community 481 
pharmacists over the age of 30. Int J Pharm Pract. 2007;15:53-59. 482 
15. Gidman WK, Hassell K, Day J, Payne K. The impact of increasing workloads and role 483 
expansion on female community pharmacists in the United Kingdom. Res Social Adm Pharm. 484 
2007;3:285-302. 485 
16. Gidman W. Increasing community pharmacy workloads in England: causes and 486 
consequences. Int J Clin Pharm. 2011;33:512-520. 487 
17. Kellar J, Paradis E, van der Vleuten CPM, oude Egbrink MGA, Austin Z. A Historical Discourse 488 
Analysis of Pharmacist Identity in Pharmacy Education. Am J Pharm Educ. 2020:ajpe7864. 489 
18. Kuipers E, Wensing M, De Smet PAGM, Teichert M. Barriers and facilitators for community 490 
pharmacists' participation in pharmacy practice research: a survey. The International journal 491 
of pharmacy practice. 2019;27:399-402. 492 
19. Awaisu A, Alsalimy N. Pharmacists' involvement in and attitudes toward pharmacy practice 493 
research: A systematic review of the literature. Res Social Adm Pharm. 2015;11:725-748. 494 
20. Crilly P, Patel N, Ogunrinde A, Berko D, Kayyali R. Community Pharmacists’ Involvement in 495 
Research in the United Kingdom. Pharmacy. 2017;5:48. 496 
21. Perreault MM, Thiboutot Z, Burry LD, et al. Canadian Survey of Critical Care Pharmacists' 497 
Views and Involvement in Clinical Research. Ann Pharmacother. 2012;46:1167-1173. 498 
22. Bhagavathula AS, Gebreyohannes EA, Gebresillassie BM, Erku DA, Negesse CT, Belay YB. 499 
Community pharmacists’ interest in and attitude to pharmacy practice research in Ethiopia: 500 
A cross-sectional study. PLoS One. 2017;12:e0178919. 501 
23. Lee R, Dahri K, Lau TTY, Shalansky S. Perceptions of Hospital Pharmacists Concerning Clinical 502 
Research: A Survey Study. The Canadian journal of hospital pharmacy. 2018;71:105-110. 503 
24. Hadi MA, José Closs S. Ensuring rigour and trustworthiness of qualitative research in clinical 504 
pharmacy. Int J Clin Pharm. 2016;38:641-646. 505 
25. Winit-Watjana W. Research philosophy in pharmacy practice: necessity and relevance. Int J 506 
Pharm Pract. 2016;24:428-436. 507 
26. Denzin NK, Lincoln YS. The SAGE handbook of qualitative research. Thousand Oaks: Sage; 508 
2011. 509 
27. Rybakov KN, Beckett R, Dilley I, Sheehan AH. Reporting quality of survey research articles 510 
published in the pharmacy literature. Res Social Adm Pharm. 2020. 511 
28. Yong FR, Garcia-Cardenas V, Williams KA, Benrimoj SI. Factors affecting community 512 
pharmacist work: a scoping review and thematic synthesis using role theory. Res Social Adm 513 
Pharm. 2020;16:123-141. 514 
29. Yong FR. Instruments measuring community pharmacist role stress and strain measures: A 515 
systematic review. Research in Social and Administrative Pharmacy. 2020. 516 
30. Lea VM, Corlett SA, Rodgers RM. Describing interruptions, multi-tasking and task-switching 517 
in community pharmacy: a qualitative study in England. Int J Clin Pharm. 2015;37:1086-1094. 518 
31. Chui MA, Stone JA. Exploring information chaos in community pharmacy handoffs. Res Social 519 
Adm Pharm. 2014;10:195-203. 520 
32. Thompson L, Bidwell S. Space, time, and emotion in the community pharmacy. Health & 521 
Place. 2015;34:251-256. 522 
33. Rapport F, Doel MA, Jerzembek GS. "Convenient space" or "a tight squeeze": insider views 523 
on the community pharmacy. Health Place. 2009;15:315-322. 524 
34. Family HE, Weiss M, Sutton J. The effects of mental workload on community pharmacists' 525 
ability to detect dispensing errors. Pharm Res UK. 2013:1-121. 526 
35. Chui MA, Look KA, Mott DA. The association of subjective workload dimensions on quality of 527 
care and pharmacist quality of work life. Res Social Adm Pharm. 2014;10:328-340. 528 
36. Gaither CA, Kahaleh AA, Doucette WR, Mott DA, Pederson CA, Schommer JC. A modified 529 
model of pharmacists' job stress: the role of organizational, extra-role, and individual factors 530 
on work-related outcomes. Res Soc Adm Pharm. 2008;4:231-243. 531 
37. Chui MA, Mott DA. Community pharmacists' subjective workload and perceived task 532 
performance: a human factors approach. J Am Pharm Assoc (2003). 2012;52:e153-e160. 533 
38. Schommer JC, Pedersen CA, Doucette WR, Gaither CA, Mott DA. Community pharmacists' 534 
work activities in the United States during 2000. J Am Pharm Assoc (Wash). 2002;42:399-535 
406. 536 
39. Benrimoj SI, Frommer MS. Community pharmacy in Australia. Aust Health Rev. 2004;28:238-537 
246. 538 
40. Grasha AF, Schell K. Psychosocial factors, workload, and human error in a simulated 539 
pharmacy dispensing task. Percept Mot Skills. 2001;92:53-71. 540 
41. Hassell K, Seston EM, Schafheutle EI, Wagner A, Eden M. Workload in community 541 
pharmacies in the UK and its impact on patient safety and pharmacists' well-being: A review 542 
of the evidence. Health and Social Care in the Community. 2011;19:561-575. 543 
42. Chui MA, Mott DA, Maxwell L. A qualitative assessment of a community pharmacy cognitive 544 
pharmaceutical services program, using a work system approach. Res Social Adm Pharm. 545 
2012;8:206-216. 546 
43. Rieck A, Pettigrew S. How physician and community pharmacist perceptions of the 547 
community pharmacist role in Australian primary care influence the quality of collaborative 548 
chronic disease management. Quality in primary care. 2013;21:105-111. 549 
44. Schommer JC, Gaither CA. A segmentation analysis for pharmacists' and patients' views of 550 
pharmacists' roles. Res Social Adm Pharm. 2014;10:508-528. 551 
45. van Eikenhorst L, Salema NE, Anderson C. A systematic review in select countries of the role 552 
of the pharmacist in consultations and sales of non-prescription medicines in community 553 
pharmacy. Research in Social and Administrative Pharmacy. 2017;13:17-38. 554 
46. Gidman W, Cowley J. A qualitative exploration of opinions on the community pharmacists' 555 
role amongst the general public in Scotland. Int J Pharm Pract. 2013;21:288-296. 556 
47. Khan MU, Khan AN, Ahmed FR, et al. Patients' opinion of pharmacists and their roles in 557 
health care system in Pakistan. J Young Pharm. 2013;5:90-94. 558 
48. Bridges D. ‘Nothing About Us Without Us’: The Ethics of Outsider Research2017:341-361. 559 
49. Elliott RA, Lee CY, Beanland C, et al. Development of a clinical pharmacy model within an 560 
Australian home nursing service using co-creation and participatory action research: the 561 
&lt;em&gt;Vi&lt;/em&gt;siting &lt;em&gt;P&lt;/em&gt;harmacist (ViP) study. BMJ Open. 562 
2017;7:e018722. 563 
50. Dineen-Griffin S, Benrimoj SI, Williams KA, Garcia-Cardenas V. Co-design and feasibility of a 564 
pharmacist-led minor ailment service. BMC Health Serv Res. 2021;21:80. 565 
51. Nørgaard LS, Sørensen EW. Action research methodology in clinical pharmacy: how to 566 
involve and change. Int J Clin Pharm. 2016;38:739-745. 567 
52. van Buul LW, Sikkens JJ, van Agtmael MA, Kramer MH, van der Steen JT, Hertogh CM. 568 
Participatory action research in antimicrobial stewardship: a novel approach to improving 569 
antimicrobial prescribing in hospitals and long-term care facilities. J Antimicrob Chemother. 570 
2014;69:1734-1741. 571 
53. Loewenson R, Flores W, Shukla A, et al. Raising the profile of participatory action research at 572 
the 2010 Global Symposium on Health Systems Research. MEDICC Rev. 2011;13:35-38. 573 
54. Bradley H. Participatory action research in pharmacy practice. Pharmacy practice research 574 
methods: Springer; 2015:91-105. 575 
55. Mannay D. Visual, Narrative and Creative Research Methods: Application, Reflection and 576 
Ethics2015. 577 
56. Iedema R, Carroll K, Collier A, Hor S-y, Mesman J, Wyer M. Video-Reflexive Ethnography in 578 
Health Research and Healthcare Improvement: Theory and Application. Florida, USA: CRC 579 
Press, Taylor & Francis Group, LLC; 2019. 580 
57. Iedema R, Hor S, Wyer M, et al. An innovative approach to strengthening health 581 
professionals’ infection control and limiting hospital-acquired infection: video-reflexive 582 
ethnography: BMJ; 2015. 583 
58. Gilbert GL, Hor S, Wyer M, Sadsad R, Badcock C-A, Iedema R. Sustained fall in inpatient 584 
MRSA prevalence after a video-reflexive ethnography project; an observational study. 585 
Infection, Disease & Health. 2020;25:140-150. 586 
59. Carroll K, Iedema R, Kerridge R. Reshaping ICU Ward Round Practices Using Video-Reflexive 587 
Ethnography. Qual Health Res. 2008;18:380-390. 588 
60. Hung L, Phinney A, Chaudhury H, Rodney P. Using Video-Reflexive Ethnography to Engage 589 
Hospital Staff to Improve Dementia Care. Global Qualitative Nursing Research. 590 
2018;5:2333393618785095. 591 
61. Mcleod HM. Respect and shared decision making in the clinical encounter, A Video-Reflexive 592 
Ethnography [Dissertation]. Minnesota, USA: Health Services Research, Policy and 593 
Administration, University of Minnesota; 2017. 594 
62. Carroll K, Mesman J. Multiple Researcher Roles in Video-Reflexive Ethnography. Qual Health 595 
Res. 2018;28:1145-1156. 596 
63. Lee YC, Wu HH, Hsieh WL, Weng SJ, Hsieh LP, Huang CH. Applying importance-performance 597 
analysis to patient safety culture. Int J Health Care Qual Assur. 2015;28:826-840. 598 
64. Nordén-Hägg A, Kälvemark-Sporrong S, Lindblad AK. Exploring the relationship between 599 
safety culture and reported dispensing errors in a large sample of Swedish community 600 
pharmacies. BMC Pharmacology and Toxicology. 2012;13. 601 
65. Johnson SJ, O'Connor EM, Jacobs S, Hassell K, Ashcroft DM. The relationships among work 602 
stress, strain and self-reported errors in UK community pharmacy. Res Social Adm Pharm. 603 
2014;10:885-895. 604 
66. Neuwirth EB, Bellows J, Jackson AH, Price PM. How Kaiser Permanente Uses Video 605 
Ethnography Of Patients For Quality Improvement, Such As In Shaping Better Care 606 
Transitions. Health Aff (Millwood). 2012;31:1244-1250. 607 
67. Swinglehurst D, Fudge N. Addressing the polypharmacy challenge in older people with 608 
multimorbidity (APOLLO-MM): study protocol for an in-depth ethnographic case study in 609 
primary care. BMJ Open. 2019;9:e031601. 610 
68. Jin HK, Choi JH, Kang JE, Rhie SJ. The effect of communication skills training on patient-611 
pharmacist communication in pharmacy education: a meta-analysis. Advances in Health 612 
Sciences Education. 2018;23:633-652. 613 
69. Iedema R, Mesman J, Carroll K. Visualising Health Care Practice Improvement: Innovation 614 
from Within2013. 615 
70. Fragkos KC. Reflective practice in healthcare education: an umbrella review. Education 616 
Sciences. 2016;6:27. 617 
71. Austin Z, Marini A, Desroches B. Use of a learning portfolio for continuous professional 618 
development: A study of pharmacists in Ontario (Canada). Pharmacy Education. 2005;5. 619 
72. Micallef R, Kayyali R. A systematic review of models used and preferences for continuing 620 
education and continuing professional development of pharmacists. Pharmacy. 2019;7:154. 621 
73. McHugh SK, Lawton R, Hara JK, Sheard L. Does team reflexivity impact teamwork and 622 
communication in interprofessional hospital-based healthcare teams? A systematic review 623 
and narrative synthesis. BMJ Quality &amp;amp; Safety. 2020;29:672. 624 
74. Collier A, Wyer M. Researching Reflexively With Patients and Families: Two Studies Using 625 
Video-Reflexive Ethnography to Collaborate With Patients and Families in Patient Safety 626 
Research. Qual Health Res. 2015;26:979-993. 627 
75. Duckett K. Community, autonomy and bespoke services: Independent community pharmacy 628 
practice in hyperdiverse, London communities. Research in Social and Administrative 629 
Pharmacy. 2015;11:531-544. 630 
76. Dobson RT, Perepelkin J. Pharmacy ownership in Canada: implications for the authority and 631 
autonomy of community pharmacy managers. Res Social Adm Pharm. 2011;7:347-358. 632 
77. Bush J, Langley CA, Wilson KA. The corporatization of community pharmacy: implications for 633 
service provision, the public health function, and pharmacy's claims to professional status in 634 
the United Kingdom. Res Soc Adm Pharm. 2009;5:305-318. 635 
78. Kahaleh A, Gaither CA. Effects of empowerment on pharmacists' organizational behaviors. J 636 
Am Pharm Assoc (2003). 2005;45:700-708. 637 
79. Kahaleh A, Gaither C. The effects of work setting on pharmacists' empowerment and 638 
organizational behaviors. Res Social Adm Pharm. 2007;3:199-222. 639 
80. Eden M, Schafheutle EI, Hassell K. Workload pressure among recently qualified pharmacists: 640 
an exploratory study of intentions to leave the profession. Int J Pharm Pract. 2009;17:181-641 
187. 642 
81. Jacobs S, Hassell K, Ashcroft D, Johnson S, O'Connor E. Workplace stress in community 643 
pharmacies in England: associations with individual, organizational and job characteristics. J 644 
Health Serv Res Policy. 2014;19:27-33. 645 
82. Perepelkin J, Dobson RT. Influence of ownership type on role orientation, role affinity, and 646 
role conflict among community pharmacy managers and owners in Canada. Res Social Adm 647 
Pharm. 2010;6:280-292. 648 
83. Norden-Hagg A, Sexton JB, Kalvemark-Sporrong S, Ring L, Kettis-Lindblad A. Assessing safety 649 
culture in pharmacies: the psychometric validation of the Safety Attitudes Questionnaire 650 
(SAQ) in a national sample of community pharmacies in Sweden. BMC Clin Pharmacol. 651 
2010;10:8. 652 
84. Dopson S, Locock L, Gabbay J, Ferlie E, Fitzgerald L. Evidence-Based Medicine and the 653 
Implementation Gap. Health (N Y). 2003;7:311-330. 654 
85. Lau R, Stevenson F, Ong BN, et al. Achieving change in primary care—causes of the evidence 655 
to practice gap: systematic reviews of reviews. Implementation Science. 2016;11:40. 656 
86. Luetsch K. Attitudes and attributes of pharmacists in relation to practice change – A scoping 657 
review and discussion. Res Social Adm Pharm. 2017;13:440-455.e411. 658 
87. Campbell C, Braund R, Morris C. Beyond the four walls: an exploratory survey of location, 659 
employment and roles of pharmacists in primary health care. J Prim Health Care. 660 
2017;9:297-310. 661 
88. Bernsten C, Andersson K, Gariepy Y, Simoens S. A comparative analysis of remuneration 662 
models for pharmaceutical professional services. Health Policy. 2010;95:1-9. 663 
89. Knoer SJ, Eck AR, Lucas AJ. A review of American pharmacy: education, training, technology, 664 
and practice. Journal of Pharmaceutical Health Care and Sciences. 2016;2:32. 665 
90. Sporrong SK, Hoglund AT, Hansson MG, Westerholm P, Arnetz B. "We are white coats 666 
whirling round"--moral distress in Swedish pharmacies. Pharm World Sci. 2005;27:223-229. 667 
91. Jacobs S, Bradley F, Elvey R, et al. Investigating the organisational factors associated with 668 
variation in clinical productivity in community pharmacies: a mixed-methods study2017. 669 
92. Lea VM, Corlett SA, Rodgers RM. Workload and its impact on community pharmacists' job 670 
satisfaction and stress: a review of the literature. Int J Pharm Pract. 2012;20:259-271. 671 
93. Rutter PM, Brown D, Jones IF. Pharmacy research: the place of work measurement. Int J 672 
Pharm Pract. 1998;6:46-58. 673 
94. Chapman CB, Wilson SG, Wilson DI, Dunkley MK. National survey of pharmacists, intern 674 
pharmacists and pharmacy students in Australia: the nature and extent of stress and well-675 
being. Int J Pharm Pract. 2020;n/a. 676 
95. Schindel TJ, Yuksel N, Breault R, Daniels J, Varnhagen S, Hughes CA. Perceptions of 677 
pharmacists' roles in the era of expanding scopes of practice. Research in social & 678 
administrative pharmacy : RSAP. 2017;13:148-161. 679 
96. Elvey R, Hassell K, Hall J. Who do you think you are? pharmacists' perceptions of their 680 
professional identity. Int J Pharm Pract. 2013;21:322-332. 681 
97. Pink S. Doing Visual Ethnography. Second Edition ed. London: SAGE Publications, Ltd; 2007. 682 
98. Rathbone AP, Jamie K. Transferring from Clinical Pharmacy Practice to Qualitative Research: 683 
Questioning Identity, Epistemology and Ethical Frameworks. Sociological Research Online. 684 
2016;21:1-9. 685 
99. Latour B. Why Has Critique Run out of Steam? From Matters of Fact to Matters of Concern. 686 
Critical Inquiry. 2004;30:225-248. 687 
 688 
